Zobrazeno 1 - 10
of 93
pro vyhledávání: '"H.J. Keizer"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Robert A. Baan, A. Luiten-Schuite, Vassilis L. Souliotis, Soterios A. Kyrtopoulos, H.J. Keizer, J. Ouwerkerk, J.H.M. van Delft
Publikováno v:
Biomarkers. 1:94-98
Methyl-DNA adducts are induced by a number of lifestyle, environmental and occupational carcinogens, however knowledge about their kinetics is scarce. Here, N7-methylguanine (N7-MeGua) and O6-methylguanine (O6-MeGua) levels were determined in the DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93989f4c41060b9354d57d710a5cfaa3
https://doi.org/10.3109/13547509609088676
https://doi.org/10.3109/13547509609088676
Publikováno v:
Drug Metabolism Reviews. 27:191-229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0dd1d7da9f5b52b9ce8755b92bb5c6f
https://doi.org/10.3109/03602539509029823
https://doi.org/10.3109/03602539509029823
Autor:
H.J Keizer
Publikováno v:
European Journal of Cancer. 36:440-442
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc570c315a07889ee7bb8a223cb78734
https://doi.org/10.1016/s0959-8049(00)00035-6
https://doi.org/10.1016/s0959-8049(00)00035-6
Autor:
H.J. Keizer
Publikováno v:
Vademecum permanente nascholing huisartsen ISBN: 9789031388073
als een predisponerende factor bij het ontstaan van het carcinoom. Pancreascarcinoom komt meer bij diabetespatienten (vooral niet insuline-afhankelijke) voor (1, 2).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7af4ef33b86ae41c260f86cbbb56bd6a
https://doi.org/10.1007/978-90-313-8808-0_1197
https://doi.org/10.1007/978-90-313-8808-0_1197
Autor:
T. Skovsgaard, C.J.A. Punt, L. Hammershaimb, J. Douma, J. Schüller, J. J. Croles, J. Zhang, E. W. Muller, H. Lochs, H.J. Keizer, C. H. H. Ten Napel
Publikováno v:
Annals of Oncology, 13, 81-6
Annals of oncology, 13(1), 81-86. Oxford University Press
Annals of Oncology, 13, 1, pp. 81-6
Annals of oncology, 13(1), 81-86. Oxford University Press
Annals of Oncology, 13, 1, pp. 81-6
Item does not contain fulltext BACKGROUND: Trimetrexate (TMTX) is a biochemical modulator of 5-fluorouracil (5-FU) and leucovorin (LV). Phase II trials have shown promising activity of 5-FU/LV/TMTX in patients with advanced colorectal cancer (ACC). T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4827ac55aa0af8f3033d5953c11d28c7
http://hdl.handle.net/2066/185518
http://hdl.handle.net/2066/185518
Autor:
Ole S. Nielsen, L. Svancarova, Ian Judson, Cédric Hermans, A. Le Cesne, Q.G.C.M. van Hoesel, J.-Y. Blay, H.J Keizer, Pancras C.W. Hogendoorn, Jaap Verweij, M. van Glabbeke, A. van Oosterom
Publikováno v:
European Journal of Cancer, 38, 556-559. Elsevier Ltd.
Svancárová, L, Blay, J Y, Judson, I R, van Hoesel, Q G C M, van Oosterom, A T, le Cesne, A, Keizer, H J, Hermans, C, van Glabbeke, M, Verweij, J, Hogendoorn, P C W & Nielsen, O S 2002, ' Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group ', European Journal of Cancer, vol. 38, no. 4, pp. 556-9 . https://doi.org/10.1016/S0959-8049(01)00408-7
Svancárová, L, Blay, J Y, Judson, I R, van Hoesel, Q G C M, van Oosterom, A T, le Cesne, A, Keizer, H J, Hermans, C, van Glabbeke, M, Verweij, J, Hogendoorn, P C W & Nielsen, O S 2002, ' Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group ', European Journal of Cancer, vol. 38, no. 4, pp. 556-9 . https://doi.org/10.1016/S0959-8049(01)00408-7
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Gemcitabine (2'-deoxy-2'-difluorocytidine monohydrochloride) at a dose of 1250 mg/m(2) was given as it 30-min intravenous (i.v.) inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c730025f18cd587a5fe93df844272158
https://pure.eur.nl/en/publications/ec0745fb-7464-4a07-a277-436f61ccf1e1
https://pure.eur.nl/en/publications/ec0745fb-7464-4a07-a277-436f61ccf1e1
Publikováno v:
Carcinogenesis. 13:1257-1259
An ELISA method was used to determine N7-methylguanine (N7-MeGua) adducts in DNA of white blood cells from cancer patients treated with the methylating antitumor drug dacarbazine by i.v. administration. From four patients who received dacarbazine onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad27fb5e4e76ba0a260d115e5f4027c9
https://doi.org/10.1093/carcin/13.7.1257
https://doi.org/10.1093/carcin/13.7.1257
Autor:
J.P. Donohue, G.C. Toner, Sophie D. Fosså, A. Gerl, Ewout W. Steyerberg, H. Schraffordt Koops, H.J. Keizer
Publikováno v:
Journal of Urology, 158, 474-478. Elsevier Inc.
Journal of Urology, 158(2), 474-478. LIPPINCOTT WILLIAMS & WILKINS
Journal of Urology, 158(2), 474-478. LIPPINCOTT WILLIAMS & WILKINS
Purpose: We determined the need and sequence of retroperitoneal lymph node dissection and thoracotomy in patients with nonseminomatous testicular cancer, and with residual retroperitoneal and pulmonary masses after chemotherapy. Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d51a41980f1ca64049d819e10bc80af6
https://pure.eur.nl/en/publications/67b70b67-dd4a-4b50-a794-d10bf6f5271b
https://pure.eur.nl/en/publications/67b70b67-dd4a-4b50-a794-d10bf6f5271b
Autor:
H.J. Keizer, E.W. Steyerberg
Publisher Summary This chapter discusses the resection of small masses of residual NSGCT and subsequent therapy. If, following chemotherapy of NSGCT, small residual tumor masses are seen on CT-scanning, surgical excision is generally accepted as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::452a89174b4e6699d715a3978fbdcc01
https://doi.org/10.1016/b978-0-08-042198-8.50058-3
https://doi.org/10.1016/b978-0-08-042198-8.50058-3